No

Corticosteroid, Ophthalmic

Treatment of inflammation after ocular surgery and the treatment of anterior uveitis

C

Fungal, viral, or untreated pus-forming bacterial ocular infections; hypersensitivity to any component

Prolonged use has been associated with the development of corneal or scleral perforation and posterior subcapsular cataracts; may mask or enhance the establishment of acute purulent untreated infections of the eye; effectiveness and safety have not been established in children

1% to 10%: Ocular: Temporary mild blurred vision

<1%: Stinging, burning eyes, corneal thinning, increased intraocular pressure, glaucoma, damage to the optic nerve, defects in visual activity, cataracts, secondary ocular infection

Systemic toxicity is unlikely from the ophthalmic preparation

Decreases inflammation by suppression of migration of polymorphonuclear leukocytes and reversal of increased capillary permeability

Absorption: Through aqueous humor

Metabolism: Any drug absorbed is metabolized in the liver

Elimination: By the kidneys and feces

Adults: Ophthalmic: Instill 1 drop in conjunctival sac 2-4 times/day up to every 4 hours; may use every 1-2 hours during first 1-2 days

Intraocular pressure and periodic examination of lens (with prolonged use)

None reported

None reported

No information available to require special precautions

No effects or complications reported

Shake well before using, do not touch dropper to the eye

Suspension, ophthalmic: 1% (5 mL, 10 mL)